Harrington, K.J.
4089  Ergebnisse:
Personensuche X
?
 
?
2

Pembrolizumab with or Without Lenvatinib As First-line Ther..:

Licitra, L. ; Tahara, M. ; Harrington, K....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e2-e3 , 2024
 
?
4

Lenvatinib ± Pembrolizumab Versus Chemotherapy for Recurren..:

Harrington, K. ; Kim, H.R. ; Salas, S....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e42 , 2024
 
?
5

Zanzalintinib Plus Pembrolizumab Versus Pembrolizumab Alone..:

Saba, N.F. ; Harrington, K. ; Licitra, L....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e40-e41 , 2024
 
?
6

SP-0190 Improving radiotherapy-induced immune stimulation b..:

Harrington, K.
Radiotherapy and Oncology.  182 (2023)  - p. S138 , 2023
 
?
 
?
9

PO-2279 Preliminary analysis of subcutaneous tissue fibrosi..:

Simoes, R. ; Gulliford, S. ; Seddon, B....
Radiotherapy and Oncology.  182 (2023)  - p. S2049-S2050 , 2023
 
?
11

Coherent Beam Shaping with Multicore Fiber Photonic Lantern:

, In: 2023 Conference on Lasers and Electro-Optics Europe & European Quantum Electronics Conference (CLEO/Europe-EQEC),
Milne, A. ; Parker, H. E. ; Wright, T. A.... - p. 1-1 , 2023
 
?
12

The biology of cancer:

Harrington, K.J. ; Nenclares, P.
Medicine.  51 (2023)  1 - p. 1-6 , 2023
 
?
13

MO-0947 Lessons learned from RT toxicity outcomes from UK V..:

Simoes, R. ; Dehbi, H. ; Gulliford, S....
Radiotherapy and Oncology.  182 (2023)  - p. S795-S796 , 2023
 
?
14

117TiP BGB-HNSCC-201 (NCT05909904): Phase II, open-label, m..:

Harrington, K.J. ; Guo, Y. ; Haddad, R....
Immuno-Oncology and Technology.  20 (2023)  - p. 100659 , 2023
 
?
 
1-15